35 /100
MEDIUM RISK
Score updated Jul 13, 2026

SAVA — Cassava Sciences Inc Dilution Risk Tracker

Track SAVA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track SAVA — Get alerts when the score changes →

As of July 13, 2026, Cassava Sciences Inc (SAVA) has a DilutionWatch DilutionScore of 35/100, rated MEDIUM dilution risk. Cassava Sciences Inc has a market capitalization of $114.97M, 48.31M shares outstanding, 105 institutional holders tracked. Key dilution vectors include approximately 20 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
25
📊 Float Risk
15
⚠️ Warrant Exposure
40
🔄Convertible Debt—

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for SAVA.
🔔 Track SAVA — Get forecast alerts →

💹 Market Data

Market Cap$114.97M
Shares Outstanding48.31M
Float42.98M
Cash$88.67M
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 18.1% shares (2026Q1 vs prior)
105 institutional holders · 18.09M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 3.86M shares
#2 MARSHALL WACE, LLP 2.01M shares
#3 TWO SIGMA INVESTMENTS, LP 1.99M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest7.17M
Days to Cover10.7
% of Float16.7%
FINRA data as of Jan 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
Full SEC filing analysis available with free account →

📰 Recent News

No recent news

📋 What This Means for SAVA Shareholders

Cassava Sciences Inc (SAVA) has a DilutionScore of 35/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for SAVA shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for SAVA in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for SAVA alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track SAVA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking SAVA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

AAT ACH AHRT ALOT AMPH

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for SAVA
📊 SAVA FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 SAVA Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.